Platelet paroxetine binding in post-traumatic stress disorder

Psychiatry Research

Volumn 77, Issue 1, 1998, Pages 1-7

  Maguire, Kay ^a   Norman, Trevor ^a   Burrows, Graham ^a   Hopwood, Malcolm ^a   Morris, Philip ^b  

^a AUSTIN HEALTH   (Australia)

^b Gold Coast Health Service District   (Australia)

Author keywords

Platelet paroxetine binding; PTSD; Serotonin

Indexed keywords

PAROXETINE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; DEPRESSION; DRUG RECEPTOR BINDING; HUMAN; LIGAND BINDING; MAJOR CLINICAL STUDY; MALE; POSTSYNAPTIC MEMBRANE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SEROTONIN RELEASE; SOLDIER; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE;

ADULT; BLOOD PLATELETS; CARRIER PROTEINS; COMBAT DISORDERS; DEPRESSIVE DISORDER, MAJOR; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; PAROXETINE; RECEPTORS, DRUG; REFERENCE VALUES; SEASONS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS;

EID: 0032536047     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(97)00133-9     Document Type: Article

References (33)

1. American Psychiatric Association, 1980. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed. American Psychiatric Association, Washington, DC.
2. American Psychiatric Association, 1987. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed., revised. American Psychiatric Association, Washington, DC.
3. Arora, R.C., Fichtner, C.G., O'Connor, F., Crayton, J.W., 1993. Paroxetine binding in the blood of platelets of posttraumatic stress disorder. Life Sciences 53, 919-928.
4. Charney, D.S., Deutch, A.Y., Krystal, J.H., Southwick, S.M., Davis, M., 1993. Psychobiologic mechanisms of posttraumatic stress disorder. Archives of General Psychiatry 50, 294-305.
5. Davidson, J., Kudler, H., Smith, R., Mahorney, S.L., Lipper, S., Hammett, E., Saunders, W.B., Cavenar, J.O., 1990. Treatment of post-traumatic stress disorder with amitriptyline and placebo. Archives of General Psychiatry 47, 259-266.
6. Davidson, J., Roth, S., Newman, J., 1991. Fluoxetine in post-traumatic stress disorder. Journal of Traumatic Stress 4, 419-423.
7. Davidson, J., Smith, R., Kudler, H., 1989. Validity and reliability of the DSMIII criteria for post-traumatic stress disorder - experience with a structured interview. Journal of Nervous and Mental Disease 177, 336-341.
8. 3H]paroxetine to platelets of depressed patients: seasonal differences and effects of diagnostic classification. Journal of Affective Disorders 32, 27-35.
9. Fichtner, C.G., Arora, R.C., O'Conner, F.L., Crayton, J.W., 1994. Platelet paroxetine binding and fluoxetine pharmacotherapy in posttraumatic stress disorder: preliminary observations on a possible predictor of clinical treatment response. Life Sciences 54, 39-44.
10. Fichtner, C.G., O'Connor, F.L., Yeoh, H.C., Arora, R.C., Crayton, J.W., 1995. Hypodensity of platelet serotonin uptake sites in post-traumatic stress disorder: Associated clinical features. Life Sciences 57, 37-44.
11. Frank, J.B., Kosten, T.R., Giller, E.L., Dan, E., 1988. A randomised clinical trial of phenelzine and imipramine for post-traumatic stress disorder. American Journal of Psychiatry 145, 1289-1291.
12. Gersons, B.P.R., Carlier, I.V.E., 1992. Post-traumatic stress disorder. The history of a recent concept. British Journal of Psychiatry 161, 742-748.
13. Hamilton, M., 1960. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 23, 56-62.
14. 2 receptors. Journal of Psychiatry and Neuroscience 20, 11-19.
15. Judd, F.K., Burrows, G.D., Norman, T.R., 1985. The biological basis of anxiety - an overview. Journal of Affective Disorders 9, 271-284.
16. Keane, T.M., Caddell, J.M., Taylor, K.L., 1988. Mississippi Scale for Combat-related Posttraumatic Stress Disorder: three studies in reliability and validity. Journal of Consulting and Clinical Psychology 56, 85-90.
17. 3H-paroxetine to blood platelets in healthy volunteers: Indications for a gender difference. Biological Psychiatry 28, 509-517.
18. 3H paroxetine, in controls and depressed patients before and after treatment with fluoxetine or lofepramine. Psychopharmacology 115, 261-264.
19. Lesch, K.P., Wolozin, B.L., Murphy, D.L., Riederer, P., 1993. Primary structure of the human platelet serotonin uptake site. Identity with the brain serotonin transporter. Journal of Neurochemistry 60, 2319-2322.
20. 3H-paroxetine binding to platelets from healthy volunteers. Biological Psychiatry 34, 356-360.
21. Mellman, T.A., Kumar, A.M., 1994. Platelet serotonin measures in posttraumatic stress disorder. Psychiatry Research 53, 99-101.
22. Meltzer, H.Y., Arora, R.C., 1991. Platelet serotonin studies in affective disorders: evidence for a serotonergic abnormality? In: Sandler, M., Coppen, A., Harnett, S. (Eds.), 5HT in Psychiatry: A Spectrum of Ideas. Oxford University Press, New York, pp. 50-89.
23. Morris, P., Hopwood, M., Marcina, J., Norman, T., Schweitzer, I., 1996. Central noradrenergic and serotonergic neurotransmitter function in chronic PTSD. European Journal of Neuropsychopharmacology 6, 81.
24. Murphy, D.L., Pigott, T.A., 1990. A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder and anxiety. Journal of Clinical Psychiatry 51, 53-60.
25. O'Keane, V., Dinan, T.G., 1991. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function. American Journal of Psychiatry 148, 1009-1015.
26. Orsillo, S.M., Weathers, F.W., Litz, B.T., Steinberg, H.R., Huska, J.A., Keane, T.M., 1996. Current and lifetime psychiatric disorders among veterans with war zone-related posttraumatic stress disorder. Journal of Nervous and Mental Disease 184, 307-313.
27. O'Toole, B.I., Marshall, R.P., Grayson, D.A., Schureck, R.J., Dobson, M., French, M., Pulvertaft, B., Meldrum, L., Bolton, J., Vennard, J., 1996. The Australian Vietnam Veterans Health Study: III. Psychological health of Australian Vietnem Veterans and its relationship to combat. International Journal of Epidemiology 25, 331-340.
28. Peroutka, S.J., Snyder, S.H., 1980. Long term antidepressant treatment decreases spiroperidol - labelled serotonin binding. Science 210, 88-90.
29. 3H-paroxetine binding to platelet and neuronal membranes. European Journal of Pharmacology 119, 1-8.
30. Schlenger, W.E., Kullen, R.A., Fairbank, J.A., Hough, R.L., Jordan, B.K., 1992. The prevalence of lifetime and partial posttraumatic stress disorder in Vietnam theatre veterans. Journal of Traumatic Stress 3, 333-363.
31. Van der Kolk, B.A., Dreyfuss, D., Michaels, M., Shera, D., Berkowitz, R., Fisler, R., Saxe, G., 1994. Fluoxetine in posttraumatic stress disorder. Journal of Clinical Psychiatry 55, 517-522.
32. Weizman, R., Laor, N., Schujovitsky, A., Wolmer, L., Abramovitz-Schnaider, P., Freudstein-Dan, A., Rehavi, M., 1996. Platelet imipramine binding in patients with posttraumatic stress disorder before and after phenelzine treatment. Psychiatry Research 63, 143-150.
33. Yehuda, R., Giller, E.L., Southwick, S.M., Lowy, M.T., Mason, J.W., 1991. Hypothalamic-pituitary-adrenal dysfunction in post-traumatic stress disorder. Biological Psychiatry 30, 1031-1048.